Hyperfine (HYPR) EPS (Diluted) Growth (1y) (2022 - 2026)
Hyperfine (HYPR) EPS (Diluted) Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -47.60% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 44.49% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 15.24% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | -25.88% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 44.97% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 15.81% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 71.72% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 13.96% |
| 10 | Hyperfine | 88.30 Mn | 43.54 Mn | 1.98 Mn | 21.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.15% |
| Mar 31, 2026 | 29.06% |
| Dec 31, 2025 | 49.63% |
| Sep 30, 2025 | 1.86% |
| Jun 30, 2025 | 16.19% |
| Mar 31, 2025 | 9.12% |
| Dec 31, 2024 | 4.23% |
| Sep 30, 2024 | 5.61% |
| Jun 30, 2024 | 5.64% |
| Mar 31, 2024 | 20.22% |
| Dec 31, 2023 | 19.18% |
| Sep 30, 2023 | 19.42% |
| Jun 30, 2023 | 54.62% |
| Mar 31, 2023 | 49.24% |
| Dec 31, 2022 | 97.38% |
| Sep 30, 2022 | 97.84% |
| Jun 30, 2022 | 96.26% |